InvestorsHub Logo
Followers 19
Posts 4094
Boards Moderated 0
Alias Born 12/17/2003

Re: None

Thursday, 02/12/2004 2:05:49 AM

Thursday, February 12, 2004 2:05:49 AM

Post# of 325
IVO.TO
Innova LifeSciences Receives Approval To Sell Endopore Dental Implant In People's Republic Of China
Wednesday January 14, 2:41 pm ET


TORONTO--(BUSINESS WIRE)--Jan. 14, 2004--Innova LifeSciences Corporation (TSX:IVO - News), a well-established leader in the global dental implant industry, today announced that the Endopore Dental Implant System has been approved for sale by the State Food and Drug Administration in the People's Republic of China (PRC). The Endopore will be distributed by the Implant Resources Centre (Far East) Ltd. of Hong Kong, and the after sales service agent responsible for technical sales support and service will be Soft Heal Dental Equipment Ltd. of Zhongshan, Guangdong Province, People's Republic of China.
"The number of dental implant procedures in China have increased dramatically over the past few years, and with the Endopore's established presence in other major economic regions within Asia, it bodes well for the company to gain market share rapidly," stated Michael Kehoe, President and CEO of Innova. "The company, with its partners in Hong Kong and the PRC, will begin an aggressive launch campaign during the first quarter of this year."

This news release may contain projections and other forward-looking statements regarding future events. Such statements are predictions which involve known and unknown risks, uncertainties and other factors which may cause the actual events or results to be materially different. For information concerning factors affecting the company's business, the reader is referred to the documents that the company files from time to time with applicable Canadian securities and regulatory authorities.

About Innova LifeSciences

Innova (www.innovalife.com) specializes in the development, manufacture and global marketing of proprietary medical devices and technologies, and is committed to continued profitable growth by advancing its technology, enriching its value proposition for customers and adding innovative complementary technologies. Endopore, the Company's brand name dental implant system, is now used by dental professionals in more than 20 countries as a preferred technology to anchor dental prostheses such as dentures, partial plates, bridgework and single teeth. A Canadian company, Innova was founded in 1988 and its technologies are approved by a wide range of health authorities, including the United States Food and Drug Administration.



--------------------------------------------------------------------------------

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.